The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating tumor DNA before and after surgical resection in patients with peritoneal carcinomatosis.
 
Joel Micah Baumgartner
Consulting or Advisory Role - Castle Biosciences
 
Kimberly C. Banks
Employment - Ambry Genetics; Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Richard Burnham Lanman
Employment - Guardant Health; Veracyte
Stock and Other Ownership Interests - Guardant Health; Veracyte
 
Lisa Tran
No Relationships to Disclose
 
Kaitlyn J. Kelly
No Relationships to Disclose
 
Andrew M. Lowy
Honoraria - Pfizer
Consulting or Advisory Role - Halozyme; Merck; Pfizer
Expert Testimony - Merck
Travel, Accommodations, Expenses - Pfizer
 
Razelle Kurzrock
Leadership - CureMatch; Novena; RScueRx
Stock and Other Ownership Interests - Actuate Therapeutics; CureMatch; Novena; RScueRx
Honoraria - AACR; AACR; Actuate Therapeutics; Casdin Capital; Casdin Capital; Casdin Capital; Casdin Capital; Cedars-Sinai; Frankel Group; Global Biomarkers Consortium; Guardant Health; Janssen; Jubilant Biosys; NCCN; NXT Health Strategies; NXT Health Strategies; Segal Cancer Center; Seminars in Oncology; Sequenom; Sequenom; Sequenom; Sequenom; Sequenom; Sequenom; Sequenom; The Dedham Group; UCSD Genomics Program Talk
Consulting or Advisory Role - AACR; Actuate Therapeutics; CTRC-EAB San Antonio; Janssen; Jubilant Biosys; Merck; SAIC NCI CCCT IDSE; Sequenom
Speakers' Bureau - Guardant Health
Research Funding - Centocor Ortho Biotech; EMD Serono; EMD Serono; EMD Serono; Exelixis; Foundation Medicine; Genentech Mypath; GlaxoSmithKline; GlaxoSmithKline; Guardant Health; Merck; Merck; Merck Serono; Novartis; Pfizer; Roche/Genentech; Sequenom; XBiotech
Patents, Royalties, Other Intellectual Property - Patent; Patent; Patent; Patent
Travel, Accommodations, Expenses - AACR; AACR; Association of American Cancer Institutes; Caris Centers of Excellence; Caris Centers of Excellence; EMD Serono; EMD Serono & Quintiles; EMD Serono & Quintiles; Gateway Research Advisory Committee; Gateway Research Advisory Committee; Global Biomarkers Consortium; Guardant Health; ICRP; WIN Pharma; WIN Pharma; WIN Pharma; WIN Pharma; WIN Pharma